ATP-binding cassette efflux transporters in human placenta

Current Pharmaceutical Biotechnology

Volumn 12, Issue 4, 2011, Pages 674-685

  Ni, Zhanglin ^a   Mao, Qingcheng ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

ABC transporters; BCRP; Fetal drug exposure; Fetus; MRPs; P gp; Transplacental drug transport

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER C1; ABC TRANSPORTER C2; ABC TRANSPORTER C3; ABC TRANSPORTER C5; ANTHRACYCLINE; ATORVASTATIN; BREAST CANCER RESISTANCE PROTEIN; CYCLOSPORIN A; DAUNORUBICIN; DIGOXIN; DOXORUBICIN; ETOPOSIDE; FEXOFENADINE; GLYCOPROTEIN P; INDINAVIR; KETOCONAZOLE; LOPERAMIDE; METHADONE; METHOTREXATE; MITOXANTRONE; NITROFURANTOIN; PACLITAXEL; PARACETAMOL; PHENYTOIN; QUINIDINE; SAQUINAVIR; TERFENADINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; XENOBIOTIC AGENT;

DNA POLYMORPHISM; DRUG INTOXICATION; DRUG TRANSPORT; FETOTOXICITY; HUMAN; PLACENTA; PREGNANT WOMAN; PRENATAL DRUG EXPOSURE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; REVIEW;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; DRUG TOXICITY; FEMALE; HUMANS; PHARMACEUTICAL PREPARATIONS; PLACENTA; POLYMORPHISM, GENETIC; PREGNANCY; PREGNANCY COMPLICATIONS;

BACTERIA (MICROORGANISMS);

EID: 79953803082     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920111795164057     Document Type: Review

References (184)

1. Enders, A. C.; Blankenship, T. N. Comparative placental structure. Adv. Drug Deliv. Rev., 1999, 38(1), 3-15.
2. Ceckova-Novotna, M.; Pavek, P.; Staud, F. P-glycoprotein in the placenta: expression, localization, regulation and function. Reprod. Toxicol., 2006, 22(3), 400-410.
3. van der Aa, E. M.; Peereboom-Stegeman, J. H.; Noordhoek, J.; Gribnau, F. W.; Russel, F. G. Mechanisms of drug transfer across the human placenta. Pharm. World Sci., 1998, 20 (4), 139-148.
4. Myren, M.; Mose, T.; Mathiesen, L.; Knudsen, L. E. The human placenta--an alternative for studying foetal exposure. Toxicol. In Vitro, 2007, 21 (7), 1332-1340.
5. Desforges, M.; Sibley, C. P. Placental nutrient supply and fetal growth. Int. J. Dev. Biol., 2009, 54(2-3), 377-390.
6. Cross, J. C. Placental function in development and disease. Reprod. Fertil. Dev., 2006, 18(1-2), 71-76.
7. Andrade, S. E.; Raebel, M. A.; Morse, A. N.; Davis, R. L.; Chan, K. A.; Finkelstein, J. A.; Fortman, K. K.; McPhillips, H.; Roblin, D.; Smith, D. H.; Yood, M. U.; Platt, R.; Gurwitz, J. H. Use of prescription medications with a potential for fetal harm among pregnant women. Pharmacoepidemiol. Drug Saf., 2006, 15(8), 546-554.
8. Glover, D. D.; Amonkar, M.; Rybeck, B. F.; Tracy, T. S. Prescription, over-the-counter, and herbal medicine use in a rural, obstetric population. Am. J. Obstet. Gynecol., 2003, 188 (4), 1039-1045.
9. Andrade, S. E.; Gurwitz, J. H.; Davis, R. L.; Chan, K. A.; Finkelstein, J. A.; Fortman, K.; McPhillips, H.; Raebel, M. A.; Roblin, D.; Smith, D. H.; Yood, M. U.; Morse, A. N.; Platt, R. Prescription drug use in pregnancy. Am. J. Obstet. Gynecol., 2004, 191(2), 398-407.
10. Behravan, J.; Piquette-Miller, M. Drug transport across the placenta, role of the ABC drug efflux transporters. Exp. Opin. Drug Metab. Toxicol., 2007, 3 (6), 819-830.
11. Gedeon, C.; Koren, G. Designing pregnancy centered medications: drugs which do not cross the human placenta. Placenta, 2006, 27 (8), 861-868.
12. Pacifici, G. M.; Nottoli, R. Placental transfer of drugs administered to the mother. Clin. Pharmacokinet., 1995, 28 (3), 235-269.
13. Syme, M. R.; Paxton, J. W.; Keelan, J. A. Drug transfer and metabolism by the human placenta. Clin. Pharmacokinet., 2004, 43 (8), 487-514.
14. Evseenko, D.; Paxton, J. W.; Keelan, J. A. Active transport across the human placenta: impact on drug efficacy and toxicity. Exp. Opin. Drug Metab. Toxicol., 2006, 2 (1), 51-69.
15. Mao, Q. BCRP/ABCG2 in the placenta: expression, function and regulation. Pharm. Res., 2008, 25(6), 1244-1255.
16. Gulati, A.; Gerk, P. M. Role of placental ATP-binding cassette (ABC) transporters in antiretroviral therapy during pregnancy. J. Pharm. Sci., 2009, 98 (7), 2317-2335.
17. Vahakangas, K.; Myllynen, P. Drug transporters in the human blood-placental barrier. Br. J. Pharmacol., 2009, 158 (3), 665-678.
18. Unadkat, J. D.; Dahlin, A.; Vijay, S. Placental drug transporters. Curr. Drug Metab., 2004, 5 (1), 125-131.
19. Juliano, R. L.; Ling, V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim. Biophys. Acta, 1976, 455 (1), 152-162.
20. Schinkel, A. H. The physiological function of drug-transporting Pglycoproteins. Semin. Cancer Biol., 1997, 8 (3), 161-170.
21. Bremer, S.; Hoof, T.; Wilke, M.; Busche, R.; Scholte, B.; Riordan, J. R.; Maass, G.; Tummler, B. Quantitative expression patterns of multidrug-resistance P-glycoprotein (MDR1) and differentially spliced cystic-fibrosis transmembrane-conductanceregulator mRNA transcripts in human epithelia. Eur. J. Biochem., 1992, 206 (1), 137-149.
22. Cordon-Cardo, C.; O'Brien, J. P.; Casals, D.; Rittman-Grauer, L.; Biedler, J. L.; Melamed, M. R.; Bertino, J. R. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at bloodbrain barrier sites. Proc. Natl. Acad. Sci. USA, 1989, 86 (2), 695-698.
23. Thiebaut, F.; Tsuruo, T.; Hamada, H.; Gottesman, M. M.; Pastan, I.; Willingham, M. C. Cellular localization of the multidrugresistance gene product P-glycoprotein in normal human tissues. Proc. Natl. Acad. Sci. USA, 1987, 84 (21), 7735-7738.
24. MacFarland, A.; Abramovich, D. R.; Ewen, S. W.; Pearson, C. K. Stage-specific distribution of P-glycoprotein in first-trimester and full-term human placenta. Histochem. J., 1994, 26 (5), 417-423.
25. Nakamura, Y.; Ikeda, S.; Furukawa, T.; Sumizawa, T.; Tani, A.; Akiyama, S.; Nagata, Y. Function of P-glycoprotein expressed in placenta and mole. Biochem. Biophys. Res. Commun., 1997, 235 (3), 849-853.
26. Sarkadi, B.; Homolya, L.; Szakacs, G.; Varadi, A. Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system. Physiol. Rev., 2006, 86 (4), 1179-1236.
27. Huls, M.; Russel, F. G.; Masereeuw, R. The role of ATP binding cassette transporters in tissue defense and organ regeneration. J. Pharmacol. Exp. Ther., 2009, 328 (1), 3-9.
28. Ushigome, F.; Takanaga, H.; Matsuo, H.; Yanai, S.; Tsukimori, K.; Nakano, H.; Uchiumi, T.; Nakamura, T.; Kuwano, M.; Ohtani, H.; Sawada, Y. Human placental transport of vinblastine, vincristine, digoxin and progesterone: contribution of P-glycoprotein. Eur. J. Pharmacol., 2000, 408 (1), 1-10.
29. Lankas, G. R.; Wise, L. D.; Cartwright, M. E.; Pippert, T.; Umbenhauer, D. R. Placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice. Reprod. Toxicol., 1998, 12 (4), 457-463.
30. Smit, J. W.; Huisman, M. T.; van Tellingen, O.; Wiltshire, H. R.; Schinkel, A. H. Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure. J. Clin. Invest., 1999, 104 (10), 1441-1447.
31. Huisman, M. T.; Smit, J. W.; Wiltshire, H. R.; Hoetelmans, R. M.; Beijnen, J. H.; Schinkel, A. H. P-glycoprotein limits oral availability, brain, and fetal penetration of saquinavir even with high doses of ritonavir. Mol. Pharmacol., 2001, 59 (4), 806-813.
32. Eyal, S.; Chung, F. S.; Muzi, M.; Link, J. M.; Mankoff, D. A.; Kaddoumi, A.; O'Sullivan, F.; Hebert, M. F.; Unadkat, J. D. Simultaneous PET imaging of P-glycoprotein inhibition in multiple tissues in the pregnant nonhuman primate. J. Nucl. Med., 2009, 50 (5), 798-806.
33. Pavek, P.; Fendrich, Z.; Staud, F.; Malakova, J.; Brozmanova, H.; Laznicek, M.; Semecky, V.; Grundmann, M.; Palicka, V. Influence of P-glycoprotein on the transplacental passage of cyclosporine. J. Pharm. Sci., 2001, 90 (10), 1583-1592.
34. Pavek, P.; Staud, F.; Fendrich, Z.; Sklenarova, H.; Libra, A.; Novotna, M.; Kopecky, M.; Nobilis, M.; Semecky, V. Examination of the functional activity of P-glycoprotein in the rat placental barrier using rhodamine 123. J. Pharmacol. Exp. Ther., 2003, 305 (3), 1239-1250.
35. Sudhakaran, S.; Ghabrial, H.; Nation, R. L.; Kong, D. C.; Gude, N. M.; Angus, P. W.; Rayner, C. R. Differential bidirectional transfer of indinavir in the isolated perfused human placenta. Antimicrob. Agents Chemother., 2005, 49 (3), 1023-1028.
36. Molsa, M.; Heikkinen, T.; Hakkola, J.; Hakala, K.; Wallerman, O.; Wadelius, M.; Wadelius, C.; Laine, K. Functional role of Pglycoprotein in the human blood-placental barrier. Clin. Pharmacol. Ther., 2005, 78 (2), 123-131.
37. Rahi, M.; Heikkinen, T.; Hakkola, J.; Hakala, K.; Wallerman, O.; Wadelius, M.; Wadelius, C.; Laine, K. Influence of adenosine triphosphate and ABCB1 (MDR1) genotype on the P-glycoproteindependent transfer of saquinavir in the dually perfused human placenta. Hum. Exp. Toxicol., 2008, 27 (1), 65-71.
38. Nanovskaya, T.; Nekhayeva, I.; Karunaratne, N.; Audus, K.; Hankins, G. D.; Ahmed, M. S. Role of P-glycoprotein in transplacental transfer of methadone. Biochem. Pharmacol., 2005, 69 (12), 1869-1878.
39. Sudhakaran, S.; Rayner, C. R.; Li, J.; Kong, D. C.; Gude, N. M.; Nation, R. L. Inhibition of placental P-glycoprotein: impact on indinavir transfer to the foetus. Br. J. Clin. Pharmacol., 2008, 65 (5), 667-673.
40. Cygalova, L. H.; Hofman, J.; Ceckova, M.; Staud, F. Transplacental pharmacokinetics of glyburide, rhodamine 123, and BODIPY FL prazosin: effect of drug efflux transporters and lipid solubility. J. Pharmacol. Exp. Ther., 2009, 331 (3), 1118-1125.
41. Gil, S.; Saura, R.; Forestier, F.; Farinotti, R. P-glycoprotein expression of the human placenta during pregnancy. Placenta, 2005, 26 (2-3), 268-270.
42. Kalabis, G. M.; Kostaki, A.; Andrews, M. H.; Petropoulos, S.; Gibb, W.; Matthews, S. G. Multidrug resistance phosphoglycoprotein (ABCB1) in the mouse placenta: fetal protection. Biol. Reprod., 2005, 73 (4), 591-597.
43. Novotna, M.; Libra, A.; Kopecky, M.; Pavek, P.; Fendrich, Z.; Semecky, V.; Staud, F. P-glycoprotein expression and distribution in the rat placenta during pregnancy. Reprod. Toxicol., 2004, 18 (6), 785-792.
44. Sun, M.; Kingdom, J.; Baczyk, D.; Lye, S. J.; Matthews, S. G.; Gibb, W. Expression of the multidrug resistance P-glycoprotein, (ABCB1 glycoprotein) in the human placenta decreases with advancing gestation. Placenta, 2006, 27 (6-7), 602-609.
45. Zhang, H.; Wu, X.; Wang, H.; Mikheev, A. M.; Mao, Q.; Unadkat, J. D. Effect of pregnancy on cytochrome P450 3a and Pglycoprotein expression and activity in the mouse: mechanisms, tissue specificity, and time course. Mol. Pharmacol., 2008, 74 (3), 714-723.
46. Mathias, A. A.; Hitti, J.; Unadkat, J. D. P-glycoprotein and breast cancer resistance protein expression in human placentae of various gestational ages. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2005, 289 (4), R963-969.
47. Nanovskaya, T. N.; Nekhayeva, I. A.; Hankins, G. D.; Ahmed, M. S. Transfer of methadone across the dually perfused preterm human placental lobule. Am. J. Obstet. Gynecol., 2008, 198 (1), 126 e1-4.
48. Kalabis, G. M.; Petropoulos, S.; Gibb, W.; Matthews, S. G. Multidrug resistance phosphoglycoprotein (ABCB1) expression in the guinea pig placenta: developmental changes and regulation by betamethasone. Can. J. Physiol. Pharmacol., 2009, 87 (11), 973-978.
49. Trezise, A. E.; Romano, P. R.; Gill, D. R.; Hyde, S. C.; Sepulveda, F. V.; Buchwald, M.; Higgins, C. F. The multidrug resistance and cystic fibrosis genes have complementary patterns of epithelial expression. EMBO. J., 1992, 11 (12), 4291-4303.
50. Petropoulos, S.; Kalabis, G. M.; Gibb, W.; Matthews, S. G. Functional changes of mouse placental multidrug resistance phosphoglycoprotein (ABCB1) with advancing gestation and regulation by progesterone. Reprod. Sci., 2007, 14 (4), 321-328.
51. Coles, L. D.; Lee, I. J.; Hassan, H. E.; Eddington, N. D. Distribution of saquinavir, methadone, and buprenorphine in maternal brain, placenta, and fetus during two different gestational stages of pregnancy in mice. J. Pharm. Sci., 2009, 98 (8), 2832-2846.
52. Smyth, M. J.; Krasovskis, E.; Sutton, V. R.; Johnstone, R. W. The drug efflux protein, P-glycoprotein, additionally protects drugresistant tumor cells from multiple forms of caspase-dependent apoptosis. Proc. Natl. Acad. Sci. USA, 1998, 95 (12), 7024-7029.
53. Scotto, K. W. Transcriptional regulation of ABC drug transporters. Oncogene 2003, 22 (47), 7496-7511.
54. Kuwano, M.; Uchiumi, T.; Hayakawa, H.; Ono, M.; Wada, M.; Izumi, H.; Kohno, K. The basic and clinical implications of ABC transporters, Y-box-binding protein-1 (YB-1) and angiogenesisrelated factors in human malignancies. Cancer Sci., 2003, 94 (1), 9-14.
55. Saji, H.; Toi, M.; Saji, S.; Koike, M.; Kohno, K.; Kuwano, M. Nuclear expression of YB-1 protein correlates with P-glycoprotein expression in human breast carcinoma. Cancer Lett., 2003, 190 (2), 191-197.
56. Zhou, S. F. Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition. Xenobiotica, 2008, 38 (7-8), 802-832.
57. Neville, M. C.; McFadden, T. B.; Forsyth, I. Hormonal regulation of mammary differentiation and milk secretion. J. Mammary Gland Biol. Neoplasia, 2002, 7 (1), 49-66.
58. Axiotis, C. A.; Guarch, R.; Merino, M. J.; Laporte, N.; Neumann, R. D. P-glycoprotein expression is increased in human secretory and gestational endometrium. Lab. Invest., 1991, 65 (5), 577-581.
59. Biing, J. T.; Yang, Y. F.; Liu, H. S.; Ye, C. T.; Chao, C. F. The induction of multidrug resistance in human cervical carcinoma cell lines by estrogenic hormones. Proc. Natl. Sci. Counc. Repub. China B, 1994, 18 (2), 64-70.
60. Kim, W. Y.; Benet, L. Z. P-glycoprotein (P-gp/MDR1)-mediated efflux of sex-steroid hormones and modulation of P-gp expression in vitro. Pharm. Res., 2004, 21 (7), 1284-1293.
61. Piekarz, R. L.; Cohen, D.; Horwitz, S. B. Progesterone regulates the murine multidrug resistance mdr1b gene. J. Biol. Chem., 1993, 268 (11), 7613-7616.
62. Coles, L. D.; Lee, I. J.; Voulalas, P. J.; Eddington, N. D. Estradiol and progesterone-mediated regulation of P-gp in P-gp overexpressing cells (NCI-ADR-RES) and placental cells (JAR). Mol. Pharm., 2009, 6 (6), 1816-1825.
63. Mutoh, K.; Tsukahara, S.; Mitsuhashi, J.; Katayama, K.; Sugimoto, Y. Estrogen-mediated post transcriptional down-regulation of Pglycoprotein in MDR1-transduced human breast cancer cells. Cancer Sci., 2006, 97 (11), 1198-1204.
64. Evseenko, D. A.; Paxton, J. W.; Keelan, J. A. Independent regulation of apical and basolateral drug transporter expression and function in placental trophoblasts by cytokines, steroids, and growth factors. Drug Metab. Dispos., 2007, 35 (4), 595-601.
65. Hemauer, S. J.; Patrikeeva, S. L.; Nanovskaya, T. N.; Hankins, G. D.; Ahmed, M. S. Opiates inhibit paclitaxel uptake by Pglycoprotein in preparations of human placental inside-out vesicles. Biochem. Pharmacol., 2009, 78 (9), 1272-1278.
66. Marzolini, C.; Paus, E.; Buclin, T.; Kim, R. B. Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance. Clin. Pharmacol. Ther., 2004, 75 (1), 13-33.
67. Takane, H.; Kobayashi, D.; Hirota, T.; Kigawa, J.; Terakawa, N.; Otsubo, K.; Ieiri, I. Haplotype-oriented genetic analysis and functional assessment of promoter variants in the MDR1 (ABCB1) gene. J. Pharmacol. Exp. Ther., 2004, 311 (3), 1179-1187.
68. Kroetz, D. L.; Pauli-Magnus, C.; Hodges, L. M.; Huang, C. C.; Kawamoto, M.; Johns, S. J.; Stryke, D.; Ferrin, T. E.; DeYoung, J.; Taylor, T.; Carlson, E. J.; Herskowitz, I.; Giacomini, K. M.; Clark, A. G. Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene. Pharmacogenetics, 2003, 13 (8), 481-494.
69. Pauli-Magnus, C.; Kroetz, D. L. Functional implications of genetic polymorphisms in the multidrug resistance gene MDR1 (ABCB1). Pharm. Res., 2004, 21 (6), 904-913.
70. Tanabe, M.; Ieiri, I.; Nagata, N.; Inoue, K.; Ito, S.; Kanamori, Y.; Takahashi, M.; Kurata, Y.; Kigawa, J.; Higuchi, S.; Terakawa, N.; Otsubo, K. Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene. J. Pharmacol. Exp. Ther., 2001, 297 (3), 1137-1143.
71. Hitzl, M.; Schaeffeler, E.; Hocher, B.; Slowinski, T.; Halle, H.; Eichelbaum, M.; Kaufmann, P.; Fritz, P.; Fromm, M. F.; Schwab, M. Variable expression of P-glycoprotein in the human placenta and its association with mutations of the multidrug resistance 1 gene (MDR1, ABCB1). Pharmacogenetics, 2004, 14(5), 309-318.
72. Rahi, M.; Heikkinen, T.; Hartter, S.; Hakkola, J.; Hakala, K.; Wallerman, O.; Wadelius, M.; Wadelius, C.; Laine, K. Placental transfer of quetiapine in relation to P-glycoprotein activity. J. Psychopharmacol., 2007, 21 (7), 751-756.
73. Hemauer, S. J.; Nanovskaya, T. N.; Abdel-Rahman, S. Z.; Patrikeeva, S. L.; Hankins, G. D.; Ahmed, M. S. Modulation of human placental P-glycoprotein expression and activity by MDR1 gene polymorphisms. Biochem. Pharmacol., 2010, 79 (6), 921-925.
74. Hutson, J. R.; Koren, G.; Matthews, S. G. Placental P-glycoprotein and breast cancer resistance protein: Influence of polymorphisms on fetal drug exposure and physiology. Placenta, 2010, 31(5), 351-357.
75. Doyle, L. A.; Yang, W.; Abruzzo, L. V.; Krogmann, T.; Gao, Y.; Rishi, A. K.; Ross, D. D. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc. Natl. Acad. Sci. USA, 1998, 95 (26), 15665-15670.
76. Miyake, K.; Mickley, L.; Litman, T.; Zhan, Z.; Robey, R.; Cristensen, B.; Brangi, M.; Greenberger, L.; Dean, M.; Fojo, T.; Bates, S. E. Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes. Cancer Res., 1999, 59 (1), 8-13.
77. Allikmets, R.; Schriml, L. M.; Hutchinson, A.; Romano-Spica, V.; Dean, M. A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. Cancer Res., 1998, 58 (23), 5337-5339.
78. Mao, Q.; Unadkat, J. D. Role of the breast cancer resistance protein (ABCG2) in drug transport. AAPS J., 2005, 7 (1), E118-133.
79. Kusuhara, H.; Sugiyama, Y. ATP-binding cassette, subfamily G (ABCG family). Pflugers Arch., 2007, 453 (5), 735-744.
80. Robey, R. W.; To, K. K.; Polgar, O.; Dohse, M.; Fetsch, P.; Dean, M.; Bates, S. E. ABCG2: a perspective. Adv. Drug Deliv. Rev., 2009, 61 (1), 3-13.
81. Zhou, L.; Naraharisetti, S. B.; Wang, H.; Unadkat, J. D.; Hebert, M. F.; Mao, Q. The breast cancer resistance protein (Bcrp1/Abcg2) limits fetal distribution of glyburide in the pregnant mouse: an obstetric-fetal pharmacology research unit network and university of washington specialized center of research study. Mol. Pharmacol., 2008, 73 (3), 949-959.
82. Gedeon, C.; Behravan, J.; Koren, G.; Piquette-Miller, M. Transport of glyburide by placental ABC transporters: implications in fetal drug exposure. Placenta, 2006, 27 (11-12), 1096-1102.
83. Merino, G.; Jonker, J. W.; Wagenaar, E.; van Herwaarden, A. E.; Schinkel, A. H. The breast cancer resistance protein (BCRP/ABCG2) affects pharmacokinetics, hepatobiliary excretion, and milk secretion of the antibiotic nitrofurantoin. Mol. Pharmacol., 2005, 67 (5), 1758-1764.
84. Borst, P.; Elferink, R. O. Mammalian ABC transporters in health and disease. Annu. Rev. Biochem., 2002, 71, 537-592.
85. Breedveld, P.; Beijnen, J. H.; Schellens, J. H. Use of Pglycoprotein and BCRP inhibitors to improve oral bioavailability and CNS penetration of anticancer drugs. Trends Pharmacol. Sci., 2006, 27 (1), 17-24.
86. Fromm, M. F. Importance of P-glycoprotein at blood-tissue barriers. Trends Pharmacol. Sci., 2004, 25 (8), 423-429.
87. Schinkel, A. H.; Jonker, J. W. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv. Drug Deliv. Rev., 2003, 55 (1), 3-29.
88. Zhou, S.; Morris, J. J.; Barnes, Y.; Lan, L.; Schuetz, J. D.; Sorrentino, B. P. Bcrp1 gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vivo. Proc. Natl. Acad. Sci. USA, 2002, 99 (19), 12339-12344.
89. Kim, R. B.; Leake, B. F.; Choo, E. F.; Dresser, G. K.; Kubba, S. V.; Schwarz, U. I.; Taylor, A.; Xie, H. G.; McKinsey, J.; Zhou, S.; Lan, L. B.; Schuetz, J. D.; Schuetz, E. G.; Wilkinson, G. R. Identification of functionally variant MDR1 alleles among European Americans and African Americans. Clin. Pharmacol. Ther., 2001, 70 (2), 189-199.
90. Cisternino, S.; Mercier, C.; Bourasset, F.; Roux, F.; Scherrmann, J. M. Expression, up-regulation, and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood-brain barrier. Cancer Res., 2004, 64 (9), 3296-3301.
91. Cooray, H. C.; Blackmore, C. G.; Maskell, L.; Barrand, M. A. Localisation of breast cancer resistance protein in microvessel endothelium of human brain. Neuroreport, 2002, 13 (16), 2059-2063.
92. Maliepaard, M.; Scheffer, G. L.; Faneyte, I. F.; van Gastelen, M. A.; Pijnenborg, A. C.; Schinkel, A. H.; van De Vijver, M. J.; Scheper, R. J.; Schellens, J. H. Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res., 2001, 61 (8), 3458-3464.
93. Wang, H.; Wu, X.; Hudkins, K.; Mikheev, A.; Zhang, H.; Gupta, A.; Unadkat, J. D.; Mao, Q. Expression of the breast cancer resistance protein (Bcrp1/Abcg2) in tissues from pregnant mice: effects of pregnancy and correlations with nuclear receptors. Am. J. Physiol. Endocrinol. Metab., 2006, 291 (6), E1295-1304.
94. Kolwankar, D.; Glover, D. D.; Ware, J. A.; Tracy, T. S. Expression and function of ABCB1 and ABCG2 in human placental tissue. Drug Metab. Dispos., 2005, 33 (4), 524-529.
95. Gedeon, C.; Anger, G.; Piquette-Miller, M.; Koren, G. Breast cancer resistance protein: mediating the trans-placental transfer of glyburide across the human placenta. Placenta, 2008, 29 (1), 39-43.
96. Ceckova, M.; Libra, A.; Pavek, P.; Nachtigal, P.; Brabec, M.; Fuchs, R.; Staud, F. Expression and functional activity of breast cancer resistance protein (BCRP, ABCG2) transporter in the human choriocarcinoma cell line BeWo. Clin. Exp. Pharmacol. Physiol., 2006, 33 (1-2), 58-65.
97. Evseenko, D. A.; Paxton, J. W.; Keelan, J. A. ABC drug transporter expression and functional activity in trophoblast-like cell lines and differentiating primary trophoblast. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2006, 290 (5), R1357-1365.
98. Myllynen, P.; Kummu, M.; Kangas, T.; Ilves, M.; Immonen, E.; Rysa, J.; Pirila, R.; Lastumaki, A.; Vahakangas, K. H. ABCG2/BCRP decreases the transfer of a food-born chemical carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in perfused term human placenta. Toxicol. Appl. Pharmacol., 2008, 232 (2), 210-217.
99. Pollex, E.; Lubetsky, A.; Koren, G. The role of placental breast cancer resistance protein in the efflux of glyburide across the human placenta. Placenta, 2008, 29 (8), 743-747.
100. Staud, F.; Vackova, Z.; Pospechova, K.; Pavek, P.; Ceckova, M.; Libra, A.; Cygalova, L.; Nachtigal, P.; Fendrich, Z. Expression and transport activity of breast cancer resistance protein (Bcrp/Abcg2) in dually perfused rat placenta and HRP-1 cell line. J. Pharmacol. Exp. Ther., 2006, 319 (1), 53-62.
101. Jonker, J. W.; Smit, J. W.; Brinkhuis, R. F.; Maliepaard, M.; Beijnen, J. H.; Schellens, J. H.; Schinkel, A. H. Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan. J. Natl. Cancer Inst., 2000, 92 (20), 1651-1656.
102. Enokizono, J.; Kusuhara, H.; Sugiyama, Y. Effect of breast cancer resistance protein (Bcrp/Abcg2) on the disposition of phytoestrogens. Mol. Pharmacol., 2007, 72 (4), 967-975.
103. Jonker, J. W.; Buitelaar, M.; Wagenaar, E.; Van Der Valk, M. A.; Scheffer, G. L.; Scheper, R. J.; Plosch, T.; Kuipers, F.; Elferink, R. P.; Rosing, H.; Beijnen, J. H.; Schinkel, A. H. The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria. Proc. Natl. Acad. Sci. USA, 2002, 99 (24), 15649-15654.
104. Zhang, Y.; Wang, H.; Unadkat, J. D.; Mao, Q. Breast cancer resistance protein 1 limits fetal distribution of nitrofurantoin in the pregnant mouse. Drug Metab. Dispos., 2007, 35 (12), 2154-2158.
105. Grube, M.; Reuther, S.; Meyer Zu Schwabedissen, H.; Kock, K.; Draber, K.; Ritter, C. A.; Fusch, C.; Jedlitschky, G.; Kroemer, H. K. Organic anion transporting polypeptide 2B1 and breast cancer resistance protein interact in the transepithelial transport of steroid sulfates in human placenta. Drug Metab. Dispos., 2007, 35 (1), 30-35.
106. Evseenko, D. A.; Murthi, P.; Paxton, J. W.; Reid, G.; Emerald, B. S.; Mohankumar, K. M.; Lobie, P. E.; Brennecke, S. P.; Kalionis, B.; Keelan, J. A. The ABC transporter BCRP/ABCG2 is a placental survival factor, and its expression is reduced in idiopathic human fetal growth restriction. FASEB J., 2007, 21 (13), 3592-3605.
107. Evseenko, D. A.; Paxton, J. W.; Keelan, J. A. The xenobiotic transporter ABCG2 plays a novel role in differentiation of trophoblast-like BeWo cells. Placenta, 2007, 28 (Suppl A), S116-120.
108. Takabe, K.; Kim, R. H.; Allegood, J. C.; Mitra, P.; Ramachandran, S.; Nagahashi, M.; Harikumar, K. B.; Hait, N. C.; Milstien, S.; Spiegel, S. Estradiol induces export of sphingosine 1-phosphate from breast cancer cells via ABCC1 and ABCG2. J. Biol. Chem., 2010, 285 (14), 10477-10486.
109. Johnstone, E. D.; Chan, G.; Sibley, C. P.; Davidge, S. T.; Lowen, B.; Guilbert, L. J. Sphingosine-1-phosphate inhibition of placental trophoblast differentiation through a G(i)-coupled receptor response. J. Lipid Res., 2005, 46 (9), 1833-1839.
110. Cygalova, L.; Ceckova, M.; Pavek, P.; Staud, F. Role of breast cancer resistance protein (Bcrp/Abcg2) in fetal protection during gestation in rat. Toxicol. Lett., 2008, 178 (3), 176-180.
111. Yasuda, S.; Itagaki, S.; Hirano, T.; Iseki, K. Expression level of ABCG2 in the placenta decreases from the mid stage to the end of gestation. Biosci. Biotechnol. Biochem., 2005, 69 (10), 1871-1876.
112. Kalabis, G. M.; Petropoulos, S.; Gibb, W.; Matthews, S. G. Breast cancer resistance protein (Bcrp1/Abcg2) in mouse placenta and yolk sac: ontogeny and its regulation by progesterone. Placenta, 2007, 28 (10), 1073-1081.
113. Meyer zu Schwabedissen, H. E.; Grube, M.; Dreisbach, A.; Jedlitschky, G.; Meissner, K.; Linnemann, K.; Fusch, C.; Ritter, C. A.; Volker, U.; Kroemer, H. K. Epidermal growth factor-mediated activation of the map kinase cascade results in altered expression and function of ABCG2 (BCRP). Drug Metab. Dispos., 2006, 34 (4), 524-533.
114. Yeboah, D.; Sun, M.; Kingdom, J.; Baczyk, D.; Lye, S. J.; Matthews, S. G.; Gibb, W. Expression of breast cancer resistance protein (BCRP/ABCG2) in human placenta throughout gestation and at term before and after labor. Can. J. Physiol. Pharmacol., 2006, 84 (12), 1251-1258.
115. Ee, P. L.; Kamalakaran, S.; Tonetti, D.; He, X.; Ross, D. D.; Beck, W. T. Identification of a novel estrogen response element in the breast cancer resistance protein (ABCG2) gene. Cancer Res., 2004, 64 (4), 1247-1251.
116. Szatmari, I.; Vamosi, G.; Brazda, P.; Balint, B. L.; Benko, S.; Szeles, L.; Jeney, V.; Ozvegy-Laczka, C.; Szanto, A.; Barta, E.; Balla, J.; Sarkadi, B.; Nagy, L. Peroxisome proliferator-activated receptor gamma-regulated ABCG2 expression confers cytoprotection to human dendritic cells. J. Biol. Chem., 2006, 281 (33), 23812-23.
117. Ebert, B.; Seidel, A.; Lampen, A. Identification of BCRP as transporter of benzo[a]pyrene conjugates metabolically formed in Caco-2 cells and its induction by Ah-receptor agonists. Carcinogenesis, 2005, 26 (10), 1754-1763.
118. Ebert, B.; Seidel, A.; Lampen, A. Phytochemicals induce breast cancer resistance protein in Caco-2 cells and enhance the transport of benzo[a]pyrene-3-sulfate. Toxicol. Sci., 2007, 96 (2), 227-236.
119. Krishnamurthy, P.; Ross, D. D.; Nakanishi, T.; Bailey-Dell, K.; Zhou, S.; Mercer, K. E.; Sarkadi, B.; Sorrentino, B. P.; Schuetz, J. D. The stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interactions with heme. J. Biol. Chem., 2004, 279 (23), 24218-24225.
120. To, K. K.; Zhan, Z.; Bates, S. E. Aberrant promoter methylation of the ABCG2 gene in renal carcinoma. Mol. Cell Biol., 2006, 26 (22), 8572-8585.
121. Wang, H.; Lee, E. W.; Zhou, L.; Leung, P. C.; Ross, D. D.; Unadkat, J. D.; Mao, Q. Progesterone receptor (PR) isoforms PRA and PRB differentially regulate expression of the breast cancer resistance protein in human placental choriocarcinoma BeWo cells. Mol. Pharmacol., 2008, 73 (3), 845-854.
122. Wang, H.; Zhou, L.; Gupta, A.; Vethanayagam, R. R.; Zhang, Y.; Unadkat, J. D.; Mao, Q. Regulation of BCRP/ABCG2 expression by progesterone and 17beta-estradiol in human placental BeWo cells. Am. J. Physiol. Endocrinol. Metab., 2006, 290 (5), E798-807.
123. Honorat, M.; Mesnier, A.; Di Pietro, A.; Lin, V.; Cohen, P.; Dumontet, C.; Payen, L. Dexamethasone down-regulates ABCG2 expression levels in breast cancer cells. Biochem. Biophys. Res. Commun., 2008, 375 (3), 308-314.
124. Yasuda, S.; Kobayashi, M.; Itagaki, S.; Hirano, T.; Iseki, K. Response of the ABCG2 promoter in T47D cells and BeWo cells to sex hormone treatment. Mol. Biol. Rep., 2009, 36 (7), 1889-1896.
125. Zhang, Y.; Zhou, G.; Wang, H.; Zhang, X.; Wei, F.; Cai, Y.; Yin, D. Transcriptional upregulation of breast cancer resistance protein by 17beta-estradiol in ERalpha-positive MCF-7 breast cancer cells. Oncology, 2006, 71 (5-6), 446-455.
126. Imai, Y.; Ishikawa, E.; Asada, S.; Sugimoto, Y. Estrogen-mediated post transcriptional down-regulation of breast cancer resistance protein/ABCG2. Cancer Res., 2005, 65 (2), 596-604.
127. Wang, H.; Unadkat, J. D.; Mao, Q. Hormonal regulation of BCRP expression in human placental BeWo cells. Pharm. Res., 2008, 25 (2), 444-452.
128. Tamura, A.; Onishi, Y.; An, R.; Koshiba, S.; Wakabayashi, K.; Hoshijima, K.; Priebe, W.; Yoshida, T.; Kometani, S.; Matsubara, T.; Mikuriya, K.; Ishikawa, T. In vitro evaluation of photosensitivity risk related to genetic polymorphisms of human ABC transporter ABCG2 and inhibition by drugs. Drug Metab. Pharmacokinet., 2007, 22 (6), 428-440.
129. Lepper, E. R.; Nooter, K.; Verweij, J.; Acharya, M. R.; Figg, W. D.; Sparreboom, A. Mechanisms of resistance to anticancer drugs: the role of the polymorphic ABC transporters ABCB1 and ABCG2. Pharmacogenomics, 2005, 6 (2), 115-138.
130. Imai, Y.; Nakane, M.; Kage, K.; Tsukahara, S.; Ishikawa, E.; Tsuruo, T.; Miki, Y.; Sugimoto, Y. C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance. Mol. Cancer Ther., 2002, 1 (8), 611-616.
131. Zamber, C. P.; Lamba, J. K.; Yasuda, K.; Farnum, J.; Thummel, K.; Schuetz, J. D.; Schuetz, E. G. Natural allelic variants of breast cancer resistance protein (BCRP) and their relationship to BCRP expression in human intestine. Pharmacogenetics, 2003, 13 (1), 19-28.
132. Kobayashi, D.; Ieiri, I.; Hirota, T.; Takane, H.; Maegawa, S.; Kigawa, J.; Suzuki, H.; Nanba, E.; Oshimura, M.; Terakawa, N.; Otsubo, K.; Mine, K.; Sugiyama, Y. Functional assessment of ABCG2 (BCRP) gene polymorphisms to protein expression in human placenta. Drug Metab. Dispos., 2005, 33 (1), 94-101.
133. Pollex, E. K.; Anger, G.; Hutson, J.; Koren, G.; Piquette-Miller, M. BCRP-mediated glyburide transport: Effect of the C421A/Q141K BCRP single nucleotide polymorphism. Drug Metab. Dispos., 2010, 38(5),740-744.
134. Altenberg, G. A. Structure of multidrug-resistance proteins of the ATP-binding cassette (ABC) superfamily. Curr. Med. Chem. Anticancer Agents, 2004, 4 (1), 53-62.
135. Higgins, C. F. ABC transporters: from microorganisms to man. Annu. Rev. Cell Biol., 1992, 8, 67-113.
136. Belinsky, M. G.; Bain, L. J.; Balsara, B. B.; Testa, J. R.; Kruh, G. D. Characterization of MOAT-C and MOAT-D, new members of the MRP/cMOAT subfamily of transporter proteins. J. Natl. Cancer Inst., 1998, 90 (22), 1735-1741.
137. Borst, P.; Evers, R.; Kool, M.; Wijnholds, J. A family of drug transporters: the multidrug resistance-associated proteins. J. Natl. Cancer Inst., 2000, 92 (16), 1295-1302.
138. Dean, M.; Rzhetsky, A.; Allikmets, R. The human ATP-binding cassette (ABC) transporter superfamily. Genome Res., 2001, 11 (7), 1156-1166.
139. Bera, T. K.; Lee, S.; Salvatore, G.; Lee, B.; Pastan, I. MRP8, a new member of ABC transporter superfamily, identified by EST database mining and gene prediction program, is highly expressed in breast cancer. Mol. Med., 2001, 7 (8), 509-516.
140. Hopper, E.; Belinsky, M. G.; Zeng, H.; Tosolini, A.; Testa, J. R.; Kruh, G. D. Analysis of the structure and expression pattern of MRP7 (ABCC10), a new member of the MRP subfamily. Cancer Lett., 2001, 162 (2), 181-191.
141. Tammur, J.; Prades, C.; Arnould, I.; Rzhetsky, A.; Hutchinson, A.; Adachi, M.; Schuetz, J. D.; Swoboda, K. J.; Ptacek, L. J.; Rosier, M.; Dean, M.; Allikmets, R. Two new genes from the human ATPbinding cassette transporter superfamily, ABCC11 and ABCC12, tandemly duplicated on chromosome 16q12. Gene, 2001, 273 (1), 89-96.
142. Nagashige, M.; Ushigome, F.; Koyabu, N.; Hirata, K.; Kawabuchi, M.; Hirakawa, T.; Satoh, S.; Tsukimori, K.; Nakano, H.; Uchiumi, T.; Kuwano, M.; Ohtani, H.; Sawada, Y. Basal membrane localization of MRP1 in human placental trophoblast. Placenta, 2003, 24 (10), 951-958.
143. Pascolo, L.; Fernetti, C.; Pirulli, D.; Crovella, S.; Amoroso, A.; Tiribelli, C. Effects of maturation on RNA transcription and protein expression of four MRP genes in human placenta and in BeWo cells. Biochem. Biophys. Res. Commun., 2003, 303 (1), 259-265.
144. St-Pierre, M. V.; Serrano, M. A.; Macias, R. I.; Dubs, U.; Hoechli, M.; Lauper, U.; Meier, P. J.; Marin, J. J. Expression of members of the multidrug resistance protein family in human term placenta. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2000, 279 (4), R1495-1503.
145. Cole, S. P.; Bhardwaj, G.; Gerlach, J. H.; Mackie, J. E.; Grant, C. E.; Almquist, K. C.; Stewart, A. J.; Kurz, E. U.; Duncan, A. M.; Deeley, R. G. Overexpression of a transporter gene in a multidrugresistant human lung cancer cell line. Science, 1992, 258 (5088), 1650-1654.
146. Breuninger, L. M.; Paul, S.; Gaughan, K.; Miki, T.; Chan, A.; Aaronson, S. A.; Kruh, G. D. Expression of multidrug resistanceassociated protein in NIH/3T3 cells confers multidrug resistance associated with increased drug efflux and altered intracellular drug distribution. Cancer Res., 1995, 55 (22), 5342-5347.
147. Chen, Z. S.; Furukawa, T.; Sumizawa, T.; Ono, K.; Ueda, K.; Seto, K.; Akiyama, S. I. ATP-Dependent efflux of CPT-11 and SN-38 by the multidrug resistance protein (MRP) and its inhibition by PAK-104P. Mol. Pharmacol., 1999, 55 (5), 921-928.
148. Chen, Z. S.; Sumizawa, T.; Furukawa, T.; Ono, K.; Tani, A.; Komatsu, M.; Akiyama, S. An enhanced active efflux of CPT-11 and SN-38 in cisplatin-resistant human KB carcinoma cells. Cancer Lett., 1999, 138 (1-2), 13-22.
149. Cole, S. P.; Sparks, K. E.; Fraser, K.; Loe, D. W.; Grant, C. E.; Wilson, G. M.; Deeley, R. G. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res., 1994, 54 (22), 5902-5910.
150. Ishikawa, T.; Akimaru, K.; Nakanishi, M.; Tomokiyo, K.; Furuta, K.; Suzuki, M.; Noyori, R. Anti-cancer-prostaglandin-induced cellcycle arrest and its modulation by an inhibitor of the ATPdependent glutathione S-conjugate export pump (GS-X pump). Biochem. J., 1998, 336 (Pt 3), 569-576.
151. Jedlitschky, G.; Leier, I.; Buchholz, U.; Barnouin, K.; Kurz, G.; Keppler, D. Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump. Cancer Res., 1996, 56 (5), 988-994.
152. Leier, I.; Jedlitschky, G.; Buchholz, U.; Center, M.; Cole, S. P.; Deeley, R. G.; Keppler, D. ATP-dependent glutathione disulphide transport mediated by the MRP gene-encoded conjugate export pump. Biochem. J., 1996, 314 (Pt 2), 433-437.
153. Leier, I.; Jedlitschky, G.; Buchholz, U.; Cole, S. P.; Deeley, R. G.; Keppler, D. The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. J. Biol. Chem., 1994, 269 (45), 27807-27810.
154. Loe, D. W.; Almquist, K. C.; Cole, S. P.; Deeley, R. G. ATPdependent 17 beta-estradiol 17-(beta-D-glucuronide) transport by multidrug resistance protein (MRP). Inhibition by cholestatic steroids. J. Biol. Chem., 1996, 271 (16), 9683-9689.
155. Muller, M.; Meijer, C.; Zaman, G. J.; Borst, P.; Scheper, R. J.; Mulder, N. H.; de Vries, E. G.; Jansen, P. L. Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proc. Natl. Acad. Sci. USA, 1994, 91 (26), 13033-13037.
156. Kruh, G. D.; Gaughan, K. T.; Godwin, A.; Chan, A. Expression pattern of MRP in human tissues and adult solid tumor cell lines. J. Natl. Cancer Inst., 1995, 87 (16), 1256-1258.
157. Atkinson, D. E.; Greenwood, S. L.; Sibley, C. P.; Glazier, J. D.; Fairbairn, L. J. Role of MDR1 and MRP1 in trophoblast cells, elucidated using retroviral gene transfer. Am. J. Physiol. Cell Physiol., 2003, 285 (3), C584-591.
158. Vaidya, S. S.; Walsh, S. W.; Gerk, P. M. Formation and efflux of ATP-binding cassette transporter substrate 2,4-dinitrophenyl-Sglutathione from cultured human term placental villous tissue fragments. Mol. Pharm., 2009, 6 (6), 1689-1702.
159. Pascolo, L.; Fernetti, C.; Garcia-Mediavilla, M. V.; Ostrow, J. D.; Tiribelli, C. Mechanisms for the transport of unconjugated bilirubin in human trophoblastic BeWo cells. FEBS Lett., 2001, 495 (1-2), 94-99.
160. Maher, J. M.; Slitt, A. L.; Cherrington, N. J.; Cheng, X.; Klaassen, C. D. Tissue distribution and hepatic and renal ontogeny of the multidrug resistance-associated protein (Mrp) family in mice. Drug Metab. Dispos., 2005, 33 (7), 947-955.
161. Lorico, A.; Rappa, G.; Finch, R. A.; Yang, D.; Flavell, R. A.; Sartorelli, A. C. Disruption of the murine MRP (multidrug resistance protein) gene leads to increased sensitivity to etoposide (VP-16) and increased levels of glutathione. Cancer Res., 1997, 57 (23), 5238-5242.
162. Wijnholds, J.; Evers, R.; van Leusden, M. R.; Mol, C. A.; Zaman, G. J.; Mayer, U.; Beijnen, J. H.; van der Valk, M.; Krimpenfort, P.; Borst, P. Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistanceassociated protein. Nat. Med., 1997, 3 (11), 1275-1279.
163. Prouillac, C.; Videmann, B.; Mazallon, M.; Lecoeur, S. Induction of cells differentiation and ABC transporters expression by a mycoestrogen, zearalenone, in human choriocarcinoma cell line (BeWo). Toxicology, 2009, 263 (2-3), 100-107.
164. Paulusma, C. C.; Kool, M.; Bosma, P. J.; Scheffer, G. L.; ter Borg, F.; Scheper, R. J.; Tytgat, G. N.; Borst, P.; Baas, F.; Oude Elferink, R. P. A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome. Hepatology, 1997, 25 (6), 1539-1542.
165. Paulusma, C. C.; Oude Elferink, R. P. The canalicular multispecific organic anion transporter and conjugated hyperbilirubinemia in rat and man. J. Mol. Med., 1997, 75 (6), 420-428.
166. Kool, M.; de Haas, M.; Scheffer, G. L.; Scheper, R. J.; van Eijk, M. J.; Juijn, J. A.; Baas, F.; Borst, P. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res., 1997, 57 (16), 3537-3547.
167. Kuo, M. T.; Bao, J. J.; Curley, S. A.; Ikeguchi, M.; Johnston, D. A.; Ishikawa, T. Frequent coordinated overexpression of the MRP/GSX pump and gamma-glutamylcysteine synthetase genes in human colorectal cancers. Cancer Res., 1996, 56 (16), 3642-3644.
168. Meyer zu Schwabedissen, H. E.; Jedlitschky, G.; Gratz, M.; Haenisch, S.; Linnemann, K.; Fusch, C.; Cascorbi, I.; Kroemer, H. K. Variable expression of MRP2 (ABCC2) in human placenta: influence of gestational age and cellular differentiation. Drug Metab. Dispos., 2005, 33 (7), 896-904.
169. Bakos, E.; Evers, R.; Sinko, E.; Varadi, A.; Borst, P.; Sarkadi, B. Interactions of the human multidrug resistance proteins MRP1 and MRP2 with organic anions. Mol. Pharmacol., 2000, 57 (4), 760-768.
170. Marin, J. J.; Macias, R. I.; Briz, O.; Perez, M. J.; Serrano, M. A. Molecular bases of the excretion of fetal bile acids and pigments through the fetal liver-placenta-maternal liver pathway. Ann. Hepatol., 2005, 4 (2), 70-76.
171. May, K.; Minarikova, V.; Linnemann, K.; Zygmunt, M.; Kroemer, H. K.; Fusch, C.; Siegmund, W. Role of the multidrug transporter proteins ABCB1 and ABCC2 in the diaplacental transport of talinolol in the term human placenta. Drug Metab. Dispos., 2008, 36 (4), 740-744.
172. Kauffmann, H. M.; Schrenk, D. Sequence analysis and functional characterization of the 5'-flanking region of the rat multidrug resistance protein 2 (mrp2) gene. Biochem. Biophys. Res. Commun., 1998, 245 (2), 325-331.
173. Simon, F. R.; Iwahashi, M.; Hu, L. J.; Qadri, I.; Arias, I. M.; Ortiz, D.; Dahl, R.; Sutherland, E. Hormonal regulation of hepatic multidrug resistance-associated protein 2 (Abcc2) primarily involves the pattern of growth hormone secretion. Am. J. Physiol. Gastrointest. Liver Physiol., 2006, 290 (4), G595-608.
174. Konig, J.; Rost, D.; Cui, Y.; Keppler, D. Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane. Hepatology, 1999, 29 (4), 1156-1163.
175. Keitel, V.; Burdelski, M.; Warskulat, U.; Kuhlkamp, T.; Keppler, D.; Haussinger, D.; Kubitz, R. Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis. Hepatology, 2005, 41 (5), 1160-1172.
176. Rost, D.; Konig, J.; Weiss, G.; Klar, E.; Stremmel, W.; Keppler, D. Expression and localization of the multidrug resistance proteins MRP2 and MRP3 in human gallbladder epithelia. Gastroenterology, 2001, 121 (5), 1203-1208.
177. Zelcer, N.; van de Wetering, K.; de Waart, R.; Scheffer, G. L.; Marschall, H. U.; Wielinga, P. R.; Kuil, A.; Kunne, C.; Smith, A.; van der Valk, M.; Wijnholds, J.; Elferink, R. O.; Borst, P. Mice lacking Mrp3 (Abcc3) have normal bile salt transport, but altered hepatic transport of endogenous glucuronides. J. Hepatol., 2006, 44 (4), 768-775.
178. Meyer Zu Schwabedissen, H. E.; Grube, M.; Heydrich, B.; Linnemann, K.; Fusch, C.; Kroemer, H. K.; Jedlitschky, G. Expression, localization, and function of MRP5 (ABCC5), a transporter for cyclic nucleotides, in human placenta and cultured human trophoblasts: effects of gestational age and cellular differentiation. Am. J. Pathol., 2005, 166 (1), 39-48.
179. Chen, Z. S.; Lee, K.; Kruh, G. D. Transport of cyclic nucleotides and estradiol 17-beta-D-glucuronide by multidrug resistance protein 4. Resistance to 6-mercaptopurine and 6-thioguanine. J. Biol. Chem., 2001, 276 (36), 33747-33754.
180. Chen, Z. S.; Lee, K.; Walther, S.; Raftogianis, R. B.; Kuwano, M.; Zeng, H.; Kruh, G. D. Analysis of methotrexate and folate transport by multidrug resistance protein 4 (ABCC4): MRP4 is a component of the methotrexate efflux system. Cancer Res., 2002, 62 (11), 3144-3150.
181. Ito, S.; Ieiri, I.; Tanabe, M.; Suzuki, A.; Higuchi, S.; Otsubo, K. Polymorphism of the ABC transporter genes, MDR1, MRP1 and MRP2/cMOAT, in healthy Japanese subjects. Pharmacogenetics, 2001, 11 (2), 175-184.
182. Lang, T.; Hitzl, M.; Burk, O.; Mornhinweg, E.; Keil, A.; Kerb, R.; Klein, K.; Zanger, U. M.; Eichelbaum, M.; Fromm, M. F. Genetic polymorphisms in the multidrug resistance-associated protein 3 (ABCC3, MRP3) gene and relationship to its mRNA and protein expression in human liver. Pharmacogenetics, 2004, 14 (3), 155-164.
183. Saito, S.; Iida, A.; Sekine, A.; Miura, Y.; Ogawa, C.; Kawauchi, S.; Higuchi, S.; Nakamura, Y. Identification of 779 genetic variations in eight genes encoding members of the ATP-binding cassette, subfamily C (ABCC/MRP/CFTR. J. Hum. Genet., 2002, 47 (4), 147-171.
184. Langmann, T.; Mauerer, R.; Zahn, A.; Moehle, C.; Probst, M.; Stremmel, W.; Schmitz, G. Real-time reverse transcription-PCR expression profiling of the complete human ATP-binding cassette transporter superfamily in various tissues. Clin. Chem., 2003, 49 (2), 230-238.